[go: up one dir, main page]

WO2007011265A8 - Procede de blocage d'activite des cibles specifiques a noggin2 - Google Patents

Procede de blocage d'activite des cibles specifiques a noggin2

Info

Publication number
WO2007011265A8
WO2007011265A8 PCT/RU2006/000382 RU2006000382W WO2007011265A8 WO 2007011265 A8 WO2007011265 A8 WO 2007011265A8 RU 2006000382 W RU2006000382 W RU 2006000382W WO 2007011265 A8 WO2007011265 A8 WO 2007011265A8
Authority
WO
WIPO (PCT)
Prior art keywords
noggin2
blocking
target specific
specific activities
proteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/RU2006/000382
Other languages
English (en)
Russian (ru)
Other versions
WO2007011265A1 (fr
Inventor
Andrei Georgievich Zaraisky
Fedor Mikhailovich Eroshkin
Andrei Vyacheslavovic Bairamov
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of WO2007011265A1 publication Critical patent/WO2007011265A1/fr
Publication of WO2007011265A8 publication Critical patent/WO2007011265A8/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1875—Bone morphogenic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/495—Transforming growth factor [TGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La présente invention concerne des protéines et notamment la protéine noggin2 régulant la différentiation cellulaire par l'inhibition des protéines de la superfamille TGF-β et des procédés de fabrication correspondants.
PCT/RU2006/000382 2005-07-21 2006-07-18 Procede de blocage d'activite des cibles specifiques a noggin2 Ceased WO2007011265A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
RU2005123287/13A RU2354662C2 (ru) 2005-07-21 2005-07-21 Способ блокирования активности activin с помощью ноггин2
RU2005123287 2005-07-21

Publications (2)

Publication Number Publication Date
WO2007011265A1 WO2007011265A1 (fr) 2007-01-25
WO2007011265A8 true WO2007011265A8 (fr) 2007-10-18

Family

ID=37669061

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/RU2006/000382 Ceased WO2007011265A1 (fr) 2005-07-21 2006-07-18 Procede de blocage d'activite des cibles specifiques a noggin2

Country Status (2)

Country Link
RU (1) RU2354662C2 (fr)
WO (1) WO2007011265A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2391352C1 (ru) * 2008-10-24 2010-06-10 Учреждение Российской академии наук Институт биоорганической химии им. академиков М.М. Шемякина и Ю.А. Овчинникова РАН СПОСОБ БЛОКИРОВАНИЯ СИГНАЛЬНОГО ПУТИ, АКТИВИРУЕМОГО TGF-beta ФАКТОРОМ VgI В КЛЕТКАХ ЖИВОТНЫХ
RU2407799C1 (ru) * 2009-06-18 2010-12-27 Учреждение Российской академии наук Институт биоорганической химии им. академиков М.М. Шемякина и Ю.А. Овчинникова РАН СПОСОБ БЛОКИРОВАНИЯ СИГНАЛЬНОГО ПУТИ, АКТИВИРУЕМОГО TGF-beta ФАКТОРОМ DERRIERE В КЛЕТКАХ ЖИВОТНЫХ

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL117175A (en) * 1995-02-20 2005-11-20 Sankyo Co Osteoclastogenesis inhibitory factor protein
US20070078101A1 (en) * 2003-01-21 2007-04-05 Brivanlou Ali H Regulation of tgf-beta signaling by tomoregulin

Also Published As

Publication number Publication date
RU2005123287A (ru) 2007-01-27
RU2354662C2 (ru) 2009-05-10
WO2007011265A1 (fr) 2007-01-25

Similar Documents

Publication Publication Date Title
AU2006272804A8 (en) Concentrated protein lyophilates, methods, and uses
GB0809236D0 (en) Valve, actuator and control system therefor
WO2008066630A3 (fr) Procédés de reprogrammation de cellules somatiques adultes, et leurs utilisations
AU2006268374A8 (en) Methods and compositions for treating ophthalmic conditions via serum retinol, serum retinol binding protein (RBP), and/or serum retinol-RBP modulation
ZA200801168B (en) Fusion proteins between plant cell-wall degrading enzymes, and their uses
EP1955177A4 (fr) Procédés, systèmes et dispositif pour marqueurs multidomaines
WO2008094945A3 (fr) Composes et procedes pour moduler l'expression des proteines
WO2006070023A3 (fr) Methode d'annulation de la multiresistance dans des cellules animales
WO2005108428A3 (fr) Variants d'epissage de cd40 et leurs utilisations
WO2007087601A8 (fr) Modulation des taux de protéines des plantes
GB2414288B (en) Hydraulic control valve, system and methods
GB0506477D0 (en) Position detection system, game system, and control method for position detection system
WO2007019178A3 (fr) Concentres proteiques de mais
WO2006034035A3 (fr) Traitement de l'ischemie
EP1895683A4 (fr) Procédé, système et programme de contrôle de communication
WO2007056083A3 (fr) Inhibiteurs de fusions polypeptidiques biosynthetiques
WO2005034840A3 (fr) Identification d'inhibiteurs de kinase
WO2007062248A3 (fr) Compositions insecticides et utilisations de celles-ci
WO2007033374A3 (fr) Compositions pharmaceutiques et procedes d'utilisation de temozolomide et d'un inhibiteur de la proteine kinase
WO2007011265A8 (fr) Procede de blocage d'activite des cibles specifiques a noggin2
WO2006047728A3 (fr) Genes bmp et proteines de fusion
WO2007057393A3 (fr) Formulations rodenticides aqueuses
WO2005091754A3 (fr) Nouveaux composes cyclopentenedione antifongiques et techniques d'utilisation de ceux-ci
WO2006015305A3 (fr) Systemes et procedes de maitrise de la mobilite ionique
HK1115817A (en) Concentrated protein lyophilates, methods, and uses

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
DPE2 Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101)
NENP Non-entry into the national phase in:

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 06784075

Country of ref document: EP

Kind code of ref document: A1